Review





Similar Products

95
Novus Biologicals rabbit polyclonal
Rabbit Polyclonal, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/53BP1+Antibody+-+BSA+Free/pmc13755912-121-24-31
Average 95 stars, based on 1 article reviews
rabbit polyclonal - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Boster Bio rabbit anti ly6g polyclonal antibody
Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative <t>Ly6G</t> immunostaining. (B) Representative cleaved caspase-1. (C) <t>Ly6G-positive</t> area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.
Rabbit Anti Ly6g Polyclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/Anti-Ms+Ly6G+Purified+Low+Endotoxin+Monoclonal+Antibody/pmc13761038-44-2-12
Average 94 stars, based on 1 article reviews
rabbit anti ly6g polyclonal antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Novus Biologicals rabbit polyclonal anti synaptophysin syn
Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative <t>Ly6G</t> immunostaining. (B) Representative cleaved caspase-1. (C) <t>Ly6G-positive</t> area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.
Rabbit Polyclonal Anti Synaptophysin Syn, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/Synaptophysin+Antibody+(SP11)/pm42962661-832-110-114
Average 92 stars, based on 1 article reviews
rabbit polyclonal anti synaptophysin syn - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
Novus Biologicals rabbit polyclonal anti numa
Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative <t>Ly6G</t> immunostaining. (B) Representative cleaved caspase-1. (C) <t>Ly6G-positive</t> area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.
Rabbit Polyclonal Anti Numa, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/NuMA+Antibody/pm42976857-222-136-139
Average 94 stars, based on 1 article reviews
rabbit polyclonal anti numa - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech rabbit anti gfap
Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative <t>Ly6G</t> immunostaining. (B) Representative cleaved caspase-1. (C) <t>Ly6G-positive</t> area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.
Rabbit Anti Gfap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/GFAP+Polyclonal+antibody/pmc13745766-271-21-24
Average 96 stars, based on 1 article reviews
rabbit anti gfap - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
ABclonal Biotechnology rabbit anti occludin polyclonal antibodies
Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, <t>occludin,</t> CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.
Rabbit Anti Occludin Polyclonal Antibodies, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/Occludin+Rabbit+pAb/pmc13744109-52-78-82
Average 97 stars, based on 1 article reviews
rabbit anti occludin polyclonal antibodies - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

98
ABclonal Biotechnology rabbit anti zo 1 polyclonal antibodies
Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of <t>ZO-1,</t> occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.
Rabbit Anti Zo 1 Polyclonal Antibodies, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/ZO-1+Rabbit+pAb/pmc13744109-52-70-74
Average 98 stars, based on 1 article reviews
rabbit anti zo 1 polyclonal antibodies - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
OriGene ggaagcgaatcaatggactctgg r
Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of <t>ZO-1,</t> occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.
Ggaagcgaatcaatggactctgg R, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/Caspase+3+(CASP3)+Rabbit+Polyclonal+Antibody/pm42998249-180-17-21
Average 94 stars, based on 1 article reviews
ggaagcgaatcaatggactctgg r - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech rabbit anti pink1 polyclonal antibodies
Eno activates mitophagy through the <t>PINK1-Parkin</t> pathway. A Western blot analysis of PINK1 in hBMECs treated with rEno for 0, 2, 4, and 6 h. β-Tubulin was used as loading control. B Representative confocal microscopy images of colocalization between PINK1 and HSP60 in hBMECs treated with vehicle or rEno. Nuclei were stained with DAPI. Scale bar: 5 μm. C Quantification of the percentage of HSP60 colocalized with PINK1. Data are mean ± s.d.; n = 53 cells from three independent experiments. Significant difference was identified using Mann–Whitney test. ***, P < 0.001. D Western blot analysis of PINK1, HSP60, TOM20, and LC3 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno treatment. β-Tubulin served as the loading control. E Confocal images of CFP-Parkin and HSP60 in WT or PINK1 KO hBMECs post-rEno treatment. Scale bar: 5 µm. F Pearson’s correlation coefficient analysis of CFP-Parkin and HSP60 colocalization from panel E. Data are mean ± s.d.; n = 51 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. *** , P < 0.001.
Rabbit Anti Pink1 Polyclonal Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/PINK1+Antibody/pmc13744109-52-86-90
Average 96 stars, based on 1 article reviews
rabbit anti pink1 polyclonal antibodies - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Novus Biologicals rabbit polyclonal antibodies against occludin
Effects of probiotics on <t>occludin</t> ( A ) and claudin-1 ( B ) positivity. Box plots showing the respective positive-pixel area fractions across groups ( n = 8 per group); this measure is a dimensionless proportion between 0 and 1. ( C ) Representative immunostained sections (100×; scale bar 100 µm).
Rabbit Polyclonal Antibodies Against Occludin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal/Occludin+Antibody+%5BHRP%5D/pmc13764108-215-35-41
Average 94 stars, based on 1 article reviews
rabbit polyclonal antibodies against occludin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative Ly6G immunostaining. (B) Representative cleaved caspase-1. (C) Ly6G-positive area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.

Journal: Journal of Oral Microbiology

Article Title: Aptamer-mediated targeting of candidalysin attenuates oral candidiasis-associated inflammation in a murine model

doi: 10.1080/20002297.2026.2737701

Figure Lengend Snippet: Neutrophil infiltration and cleaved caspase-1 staining in murine oral candidiasis. (A) Representative Ly6G immunostaining. (B) Representative cleaved caspase-1. (C) Ly6G-positive area (% area) in tongue mucosa. (D) Ly6G-positive area (% area) in buccal mucosa. (E) Cleaved caspase-1-positive area (% area) in tongue mucosa. (F) Cleaved caspase-1-positive area (% area) in buccal mucosa. Each panel is headed with the tissue and the marker quantified. Data are mean ± SD ( n = 6 mice per group; animal-level means of three fields per tissue). Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparisons test against the Inf group; **** P < 0.0001; ns, not significant. Comparisons with the NC group and with NaHCO₃ are not annotated.

Article Snippet: For immunohistochemistry, rabbit anti-Ly6G polyclonal antibody (cat. no. A30404-1) were obtained from Boster Biological Technology Co., Ltd. (Beijing, China); rabbit anti-cleaved caspase-1 polyclonal antibody (cat. no. AF4005) were obtained from Jiangsu Affinity Biosciences Co., Ltd. (Jiangsu, China); the HRP-conjugated secondary antibody (cat. no. BA1054), SABC reagent (cat. no. SA1029) and DAB substrate kit (cat. no. AR1027) were from Boster Biological Technology Co., Ltd. (Beijing, China).

Techniques: Staining, Immunostaining, Tissue, Marker, Analysis

Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Western Blot, Analysis, Control, Over Expression, Confocal, Microscopy, Staining, Knock-Out, Infection, Immunohistochemical staining, Mutagenesis

Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Western Blot, Analysis, Control, Over Expression, Confocal, Microscopy, Staining, Knock-Out, Infection, Immunohistochemical staining, Mutagenesis

Eno activates mitophagy through the PINK1-Parkin pathway. A Western blot analysis of PINK1 in hBMECs treated with rEno for 0, 2, 4, and 6 h. β-Tubulin was used as loading control. B Representative confocal microscopy images of colocalization between PINK1 and HSP60 in hBMECs treated with vehicle or rEno. Nuclei were stained with DAPI. Scale bar: 5 μm. C Quantification of the percentage of HSP60 colocalized with PINK1. Data are mean ± s.d.; n = 53 cells from three independent experiments. Significant difference was identified using Mann–Whitney test. ***, P < 0.001. D Western blot analysis of PINK1, HSP60, TOM20, and LC3 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno treatment. β-Tubulin served as the loading control. E Confocal images of CFP-Parkin and HSP60 in WT or PINK1 KO hBMECs post-rEno treatment. Scale bar: 5 µm. F Pearson’s correlation coefficient analysis of CFP-Parkin and HSP60 colocalization from panel E. Data are mean ± s.d.; n = 51 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. *** , P < 0.001.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Eno activates mitophagy through the PINK1-Parkin pathway. A Western blot analysis of PINK1 in hBMECs treated with rEno for 0, 2, 4, and 6 h. β-Tubulin was used as loading control. B Representative confocal microscopy images of colocalization between PINK1 and HSP60 in hBMECs treated with vehicle or rEno. Nuclei were stained with DAPI. Scale bar: 5 μm. C Quantification of the percentage of HSP60 colocalized with PINK1. Data are mean ± s.d.; n = 53 cells from three independent experiments. Significant difference was identified using Mann–Whitney test. ***, P < 0.001. D Western blot analysis of PINK1, HSP60, TOM20, and LC3 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno treatment. β-Tubulin served as the loading control. E Confocal images of CFP-Parkin and HSP60 in WT or PINK1 KO hBMECs post-rEno treatment. Scale bar: 5 µm. F Pearson’s correlation coefficient analysis of CFP-Parkin and HSP60 colocalization from panel E. Data are mean ± s.d.; n = 51 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. *** , P < 0.001.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Western Blot, Analysis, Control, Confocal, Microscopy, Staining, MANN-WHITNEY, Knock-Out

Eno-induced mitophagy disrupts the integrity of BBB. A EB permeation assay in hBMEC monolayers treated with rEno-WT or rENO-ΔH2, with or without Mdivi-1 pretreatment. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05, **, P < 0.01, ***, P < 0.001. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, in the presence and absence of PINK1 knockout. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. ***, P < 0.001. C The quantification of EB penetrated into brains of C57 mice infected with the WT strain or the eno -ΔH2 mutant strain, with or without Mdivi-1 treatment. Data are mean ± s.d.; n = 6. Significant differences were identified using a one-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05. D The bacterial load in the brains of C57 mice infected with the WT strain or the eno -ΔH2 mutant strain, with or without Mdivi-1 treatment. Data are mean ± s.d.; n = 6. Significant differences were identified using a one-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Eno-induced mitophagy disrupts the integrity of BBB. A EB permeation assay in hBMEC monolayers treated with rEno-WT or rENO-ΔH2, with or without Mdivi-1 pretreatment. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05, **, P < 0.01, ***, P < 0.001. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, in the presence and absence of PINK1 knockout. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. ***, P < 0.001. C The quantification of EB penetrated into brains of C57 mice infected with the WT strain or the eno -ΔH2 mutant strain, with or without Mdivi-1 treatment. Data are mean ± s.d.; n = 6. Significant differences were identified using a one-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05. D The bacterial load in the brains of C57 mice infected with the WT strain or the eno -ΔH2 mutant strain, with or without Mdivi-1 treatment. Data are mean ± s.d.; n = 6. Significant differences were identified using a one-way ANOVA followed by Dunnett’s multiple comparisons test. *, P < 0.05.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Knock-Out, Infection, Mutagenesis

Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Eno-mediated induction of mitophagy results in the depletion of CLDN5. A Western blot analysis of ZO-1, occludin, CLDN5, and LC3 protein levels in hBMECs over 0–6 h of rEno stimulation. β-Tubulin was used as the loading control. B EB permeation assay in hBMEC monolayers treated with rEno-WT or vehicle, with or without the overexpression of CLDN5. Data are mean ± s.d.; n = 3. Significant differences were identified using a two-way ANOVA followed by Dunnett’s multiple comparisons test. **, P < 0.01. C Representative confocal microscopy images of colocalization between CLDN5 and HSP60 in hBMECs. Nuclei were stained with DAPI. Scale bar: 5 μm. D Representative confocal images showing localization between CLDN5 and LAMP1 in hBMECs pretreated with Mdivi-1 or BafA1 followed by the addition of rEno-WT. Nuclei were stained with DAPI. Scale bar: 5 μm. E Pearson’s correlation coefficient analysis of CLDN5 and LAMP1 colocalization from panel D. Data are mean ± s.d.; n = 50 cells from three independent experiments. Significant differences were identified using Kruskal–Wallis test. ***, P < 0.001. F Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs pretreated with or without Mdivi-1 before vehicle or rEno-WT treatment. β-Tubulin was used as the loading control. G Western blot analysis of CLDN5 in hBMECs treated with vehicle, rEno-WT or rEno-ΔH2. β-Tubulin was used as the loading control. H Western blot analysis of CLDN5 in wild-type (WT) and PINK1 knockout (PINK1 KO) hBMECs, with or without rEno-WT treatment. β-Tubulin served as the loading control. I Western blot analysis of HSP60, TOM20, CLDN5, and LC3 in hBMECs infected with wild-type (WT), eno :: kan , or eno -ΔH2 strains. Uninfected cells served as control. β-Tubulin was used as loading control. J Immunohistochemical analysis of the protein level of CLDN5 in brain tissues from mice infected with the WT strain or the eno-ΔH2 mutant strain, as well as from uninfected control mice. Scale bar: 50 μm.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Western Blot, Analysis, Control, Over Expression, Confocal, Microscopy, Staining, Knock-Out, Infection, Immunohistochemical staining, Mutagenesis

Diagram summarizing the mechanism by which Eno induces mitophagy, leading to the disruption of the BBB. SS2 enolase interacts with host HSP90AA1 via its N-terminal second α-helix (residues 87–98). This interaction potentially impairs HSP90AA1 function, causing misfolded protein accumulation in mitochondria. The proteostasis stress activates the PINK1-Parkin pathway, inducing mitophagy. Eno-triggered mitophagy leads to the degradation of the tight junction protein CLDN5 in brain endothelial cells, disrupting BBB integrity and facilitating bacterial meningitis.

Journal: Veterinary Research

Article Title: Streptococcus suis -induced mitophagy via Eno-HSP90AA1 interaction disrupts the blood–brain barrier

doi: 10.1186/s13567-026-01860-5

Figure Lengend Snippet: Diagram summarizing the mechanism by which Eno induces mitophagy, leading to the disruption of the BBB. SS2 enolase interacts with host HSP90AA1 via its N-terminal second α-helix (residues 87–98). This interaction potentially impairs HSP90AA1 function, causing misfolded protein accumulation in mitochondria. The proteostasis stress activates the PINK1-Parkin pathway, inducing mitophagy. Eno-triggered mitophagy leads to the degradation of the tight junction protein CLDN5 in brain endothelial cells, disrupting BBB integrity and facilitating bacterial meningitis.

Article Snippet: For immunofluorescence or western blot, the following antibodies were applied: Rabbit anti-LC3A/B monoclonal antibodies (Cell Signaling Technology, 12,741, western 1:1000, immunofluorescence 1:200); Rabbit anti-LAMP1 monoclonal antibodies (Abclonal, A16894, immunofluorescence 1:200); Mouse anti-LAMP1 monoclonal antibodies (Beyotime, AG2482, immunofluorescence 1:50); Rabbit anti-TOM20 monoclonal antibodies (Beyotime, AF1717, western 1:1000, immunofluorescence 1:200); Mouse anti-HSP60 monoclonal antibodies (Beyotime, AF0186, western 1:1000, immunofluorescence 1:200); Rabbit anti-CLDN5 polyclonal antibodies (Proteintech, 29767-1-AP, western 1:500, immunofluorescence 1:100, IHC 1:800); Rabbit anti-ZO-1 polyclonal antibodies (Abclonal, A0659, western 1:500); Rabbit anti-occludin polyclonal antibodies (Abclonal, A2601, western 1:500); Rabbit anti-PINK1 polyclonal antibodies (Proteintech, 23274–1-AP, western 1:500, immunofluorescence 1:200); Mouse anti-β-Tubulin monoclonal antibodies (Proteintech, 10068-1-AP, western 1:1000); Rabbit anti-His monoclonal antibodies (Cell Signaling Technology, 12698, western 1:1000); Rabbit anti-HA monoclonal antibodies (Cell Signaling Technology, 3724, western 1:1000); Mouse anti-FLAG monoclonal antibodies (Sigma, F1804, western 1:1000, immunofluorescence 1:400); Mouse anti-Eno polyclonal antibodies(Produced by our lab, western 1:500, immunofluorescence 1:200); HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibodies (Beyotime, A0208, western 1:1000); HRP-conjugated goat anti-mouse IgG (H + L) secondary antibodies (Beyotime, A0216, western 1:1000); YSFluor 488 goat anti-rabbit IgG (H + L) secondary antibodies (Yeasen, 33106ES60, immunofluorescence 1:200); YSFluor 594 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33212ES60, immunofluorescence 1:200); YSFluor 647 goat anti-mouse IgG (H + L) secondary antibodies (Yeasen, 33213ES60, immunofluorescence 1:200).

Techniques: Disruption

Effects of probiotics on occludin ( A ) and claudin-1 ( B ) positivity. Box plots showing the respective positive-pixel area fractions across groups ( n = 8 per group); this measure is a dimensionless proportion between 0 and 1. ( C ) Representative immunostained sections (100×; scale bar 100 µm).

Journal: International Journal of Molecular Sciences

Article Title: Effects of a Two-Strain Lactobacillus Formulation ( Lactobacillus rhamnosus L34 and Lactobacillus paracasei B13) on Inflammatory and Oxidative Markers, Epithelial Junction Proteins, and Fecal Microbiota in Rats with DNBS-Induced Colitis

doi: 10.3390/ijms27219961

Figure Lengend Snippet: Effects of probiotics on occludin ( A ) and claudin-1 ( B ) positivity. Box plots showing the respective positive-pixel area fractions across groups ( n = 8 per group); this measure is a dimensionless proportion between 0 and 1. ( C ) Representative immunostained sections (100×; scale bar 100 µm).

Article Snippet: Slides were then incubated with high-sensitivity streptavidin-HRP conjugate (HSS-HRP) for 30 min and developed with DAB chromogen solution for 15 min. For occludin and claudin-1, sections were incubated at room temperature for 1 h with rabbit polyclonal antibodies against occludin (1:500; Novus Biologicals, USA) and claudin-1 (1:200; Novus Biologicals, USA), followed by overnight incubation at 4 °C in a humidified chamber.

Techniques: Probiotics